Ryan Halsted
Stock Analyst at RBC Capital
(0.25)
# 4,417
Out of 5,132 analysts
6
Total ratings
25%
Success rate
-13.61%
Average return
Main Sectors:
Stocks Rated by Ryan Halsted
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDLN Medline | Initiates: Outperform | $47 | $44.59 | +5.40% | 1 | Jan 12, 2026 | |
| PRVA Privia Health Group | Reinstates: Outperform | $31 | $21.50 | +44.19% | 1 | Jan 9, 2026 | |
| TBRG TruBridge | Reinstates: Sector Perform | $23 | $18.85 | +22.02% | 1 | Jan 9, 2026 | |
| ENSG The Ensign Group | Downgrades: Underperform | n/a | $214.41 | - | 3 | Apr 28, 2017 |
Medline
Jan 12, 2026
Initiates: Outperform
Price Target: $47
Current: $44.59
Upside: +5.40%
Privia Health Group
Jan 9, 2026
Reinstates: Outperform
Price Target: $31
Current: $21.50
Upside: +44.19%
TruBridge
Jan 9, 2026
Reinstates: Sector Perform
Price Target: $23
Current: $18.85
Upside: +22.02%
The Ensign Group
Apr 28, 2017
Downgrades: Underperform
Price Target: n/a
Current: $214.41
Upside: -